GENERIC NAME: erythromycin
BRAND NAMES: Eryc, Ery-Tab, E.E.S, Eryped, PCE, (E-Mycin, Ilosone, and Pediazole are discontinued brands)
DRUG CLASS AND MECHANISM: Erythromycin is an antibiotic in the class of antibiotics known as macrolide antibiotics which also includes azithromycin (Zithromax, Zmax) and clarithromycin (Biaxin). It is used to treat several types of infections including upper/lower respiratory tract infections, skin infections, acute pelvic inflammatory disease, erythrasma, etc. caused by bacteria such as Streptococcus pyogenes, Streptococcus pneumoniae, Mycoplasma pneumoniae, Staphylococcus aureus, Neisseria gonorrhoeae, and many others. Erythromycin, like all macrolide antibiotics, prevents bacterial cells from growing and multiplying by interfering with their ability to make proteins while not affecting human cells. Bacteria such as Haemophilus influenzae are resistant to erythromycin alone and must be treated with a combination of erythromycin and adequate doses of sulfonamides. The FDA approved E.E.S in April 1965.
GENERIC AVAILABLE: Yes
PREPARATIONS: Tablets: Tablets: 250, 333, 400 and 500 mg. Suspension: 200 and, 400 mg/teaspoon. Tablet (Chewable): 200 mg. Powder: 100 mg/half-teaspoon and 200 mg/teaspoon. Granules: 200 and 400 mg/teaspoon. Powder for Injection: 500 mg and 1g.
STORAGE: Erythromycin should be stored at temperatures below 86 F (30 C). It is important to protect tablets from moisture and excessive heat.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.